<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">175</article-id>
      <article-id pub-id-type="doi">10.31348/2020/34</article-id>
      <article-categories>
        <subj-group>
          <subject>Original article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Transscleral Diode Cyclophotocoagulation in Treatment of Glaucoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Farraová</surname>
            <given-names>Petra</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ondrejková</surname>
            <given-names>Marta</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Demianová</surname>
            <given-names>Daniela</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>20</day>
        <month>12</month>
        <year>2020</year>
      </pub-date>
      <issue>5</issue>
      <elocation-id>6</elocation-id>
      <abstract>
        <p>Aim: To assess efficiency and safety of diode cyclophotocoagulation (CPC). Methods: Retrospective study included 81 eyes with advanced glaucoma operated with CPC for elevated intraocular pressure (IOP) from January 2017 to January 2019. CPC was performed in retrobulbar anesthesia with contact diode laser FOX (A.R.C. Laser, Germany) of wavelength 810 nm, transsclerally to the ciliary body. Energy settings: intensity 2 W, exposition time 2 s, 18 applications in arc of 360°. Decrease of intraocular pressure was investigated during month 1, 6 and 12 after CPC. Safety was evaluated according to the best corrected visual acuity (BCVA) on Snellen optotypes and number of postoperative complications. Results: Study on 31 eyes of 24 patients, 21 (68 %) women and 10 (32 %) men, with follow-up during more than 12 months. Mean follow-up time was 19.5 ± 6.1 (from 12 to 29) months. Average age was 75.9 ± 9.2 (56 - 93) years. Indication for CPC was primary open angle glaucoma in 15 eyes (49 %), primary angle closure glaucoma in 6 eyes (19 %) and secondary glaucomas in 10 eyes (32 %). All patients were on therapy of 4 antiglaucomatic drops and 10 of them (32 %) on acetazolamide pills. IOP before CPC was 25.4 ± 11.0 (13–56) mm Hg. After 1 year IOP decreased to 16.9 ± 6.1 (8–40) mm Hg. Best corrected visual acuity (BCVA) before CPC was 0.39 ± 0.34 (0-1), 1 year after CPC 0.36 ± 0.33 (0-1). 1 year after CPC, 11 eyes (35 %) lost 0.23 ± 0.14 rows. 6 from these (19 %) due to other acquired ocular pathologies. Hypotony occurred in 6 % and uveitis in 10 % eyes. Conclusion: CPC is a safe and effective method of lowering IOP.</p>
      </abstract>
      <kwd-group>
        <kwd>cyclophotocoagulation</kwd>
        <kwd>advanced glaucoma</kwd>
        <kwd>refractory glaucoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R6283">
        <mixed-citation>Pastor S, Singh K, Lee D, et al. Cyclophotocoagulation. Ophtalmology. 2001 Nov;108(11):2130-2138.</mixed-citation>
      </ref>
      <ref id="R6284">
        <mixed-citation>Dastiridou AI, Katsanos A, Denis P, et al. Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options. Adv Ther. 2018 Nov;35:2103–2127.</mixed-citation>
      </ref>
      <ref id="R6285">
        <mixed-citation>Bloom PA, Negi AK, Kersey TL, Crawley L. Cyclodestructive Techniques. In: Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG: Glaucoma Surgical Management. Philadelphia: Elsevier Saunders Ltd.; c2015. Chapter 17, Cyclodestructive procedures; p. 1150–1170. ISBN: 978-0-7020-5193-7.</mixed-citation>
      </ref>
      <ref id="R6286">
        <mixed-citation>Huang G, Lin S. When should we give up filtration surgery: Indications, Techniques and Results of Cyclodestruction. Dev Ophtalmol. 2012;50:173–183.</mixed-citation>
      </ref>
      <ref id="R6287">
        <mixed-citation>Giaconi J, Law S, Nouri-Mahdavi K, Coleman AL, Caprioli J. Pearls of Glaucoma Management. Berlin (Germany): Springer; c2016. Chapter 34, Procedural Treatments: Transscleral Cyclophotocoagulation. p. 311–318.</mixed-citation>
      </ref>
      <ref id="R6288">
        <mixed-citation>American Academy of Ophthalmology (AAO). Cyclodestructive Procedures in Treatment of Glaucoma. [internet]. AAO; 2019. Available from: https://eyewiki.aao.org/Cyclodestructive_ Procedures_ in_Treatment_of_Glaucoma.</mixed-citation>
      </ref>
      <ref id="R6289">
        <mixed-citation>Kahook MY, Schumal JS. Complications of Cyclodestructive Procedures. In: Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG: Glaucoma Surgical Management. Philadelphia: Elsevier Saunders Ltd.; c2015. Chapter 17, Cyclodestructive precedures; p. 1150– 1170. ISBN: 978-0-7020-5193-7.</mixed-citation>
      </ref>
      <ref id="R6290">
        <mixed-citation>Aujla JS, Lee GA, Vincent SJ, Thomas R. Incidence of hypotony and symphatetic ophthalmia following trans-scleral cyclophotocoagulation for glaucoma and a report of risk factors. Clin Exp Ophtalmol. 2013;41(8):761–772.</mixed-citation>
      </ref>
      <ref id="R6291">
        <mixed-citation>Contreras I, Noval S, González Martín-Moro J, Rebolleda G, Muñoz- -Negrete FJ. IOP spikes following contact transscleral diode laser cyclophotocoagulation. Arch Soc Esp Oftalmol. 2004;79(3):105– 109.</mixed-citation>
      </ref>
      <ref id="R6292">
        <mixed-citation>Nutterová E, Pitrová Š, Lešták J. Our experience with micropulse cyclophotocoagulation in the therapy of glaucoma. Cesk Slov Oftalmol. 2020;76(1):29-36. Available from: http://www.cs-ophthalmology.cz/en/journal/articles/144</mixed-citation>
      </ref>
      <ref id="R6293">
        <mixed-citation>Kosoko O, Gaasterland DE, Pollack IP, Enger CL. Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The diode laser ciliary ablation study group. Ophthalmology. 1996;103:1294–1302.</mixed-citation>
      </ref>
      <ref id="R6294">
        <mixed-citation>Fox J. Cyclophotocoagulation controversy. [Internet]. Glaucoma Today; c2017 [cited 2020 Apr 25]. Available from: https://glaucomatoday.com/articles/2017-mar-apr/cyclophotocoagulation-controversy.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
